Dunica is led by an interdisciplinary team of specialists who combine years of clinical experience and scientific expertise to revolutionize the world of T1 diabetes therapy.
Founders
CEO
Daniella Givon
Entrepreneur of translational science ventures
Daniella is a clinical herbalist specializing in integrated herbology and mother to a T1 Diabetic child. She has 15 years of experience in botanical supplementation development and regulatory affairs, manufacturing, and business development. Daniella is also a senior lecturer and a consultant to Foodtech and BioMed VCs and startup companies.
Director
Nadav Shraibom
Researcher specializing in autoimmune diseases
Nadav is a Traditional Chinese Medicine (TCM) practitioner, researcher and entrepreneur. After completing his MSc, Nadav worked as a private practitioner specializing in autoimmune diseases, dermatology, infertility, and cancer. Following 20 years of clinical work, Nadav co-founded an innovative venture developing effective skincare utilizing a combination of traditional Chinese knowledge and advanced science. In the process, he developed and registered 12 different patents in the EU & USA, with more pending.
Head of Preclinical Studies, co-founder
Raanan Margalit
Immunologist with over 20 years of experience.
Raanan is an active researcher who specializes in the planning and management of pre-clinical animal studies for MedTech and drug discovery ventures, as well as the development of experimental animal models for early-stage biopharmaceutical companies. Raanan’s expertise emphasizes autoimmune and inflammatory diseases, cancer, neurodegenerative disorders, and disease models involving surgical procedures and/or transplantation. Extensive experience in accompanying and biopharma companies from inception to market.
Research and Development
Head of Chemical Research
Dr. Avi Raveh, Ph.D.
Scientific director of Chemistry, Nanotechnology & Energy Materials at Israel's Ministry of Science & Technology
Dr. Raveh is an active researcher specializing in medicinal chemistry and focusing on naturally derived products. He joined the Blavatnik Center for Drug Discovery as the head of the Medicinal Chemistry Unit and was later promoted to Chief Scientific officer. In 2018, Dr. Raveh joined the editorial board of "Drug Development Research" (Wiley). Today, Dr. Raveh is the Director of Chemistry, Materials, Nanotechnology, and Energy in Israel's Ministry of Innovation.
Head of Clinical Development (up to 2025)
Prof. Marianna Rachmiel, M.D.
Head of Pediatric Endocrinology and Diabetes Institute, Shamir (Assaf Haroffeh Medical Center) Associate Professor at Sackler School of Medicine, Tel-Aviv University.
Since completing her Pediatric Endocrinology fellowship at Toronto’s Children's Hospital in 2006, Mariana has published nearly 80 publications in peer-reviewed journals, mainly on type 1 diabetes, general pediatric endocrinology, and metabolism. She was the principal investigator in several researches, both identifying the immune mechanism of type 1 diabetes and in the treatment of new-onset type 1 diabetes (stage 3), and presented her work at several international conventions. In the last decade, She has also been a reviewer at several journals, including the Journal of Pediatrics, Acta Diabetologica, Pediatric Diabetes, and JCEM.
Scientific Consultant
Dr. Kfir Lapid, Ph.D.
Biomedical writer and consultant, based
in Germany
Dr. Lapid is a data-driven biomedical writer and consultant with a strong scientific research background. He provides services across various therapeutic areas. His consultancy expertise involves supporting the transition from pre-clinical research to clinical research stages in start-up companies. Dr. Lapid is an active member of the European Medical Writers Association.
Advisory
Head of Pharmaceutical Unit
Dr. Urs Wiedemann, Ph.D
Founder and Managing Partner of Stradoo, a biosciences-focused strategy consulting firm
Urs has worked with a long list of pharmaceutical companies and biotech startups on long-term strategy, commercialization strategy, M&A, and Venture Capital cases. Stradoo's partners combine more than 100 years of experience in the life sciences industries – pharmaceuticals, medical devices, and diagnostics – providing advice during hundreds of projects on highly strategic questions to its clients.
Legal advisor
Yaniv Aronovich
Legal advisor, Chief Legal Officer at accessiBe, a leader in web accessibility solutions.
Yaniv was a tech and M&A partner at Tadmor & Co. Yuval Levy & Co., one of Israel's fastest-growing independent law firms. Graduated law school at HUJI and public law affairs at TAU.
Medical advisor
Prof. Amir Tirosh, Md
Director at Sheba medical center, Division of Endocrinology, Diabetes and Metabolism
Dr. Tirosh receiverd his MD (Summa Cum Laude) and PhD in Biochemistry from Ben-Gurion University in Israel. He completed a residency in Internal Medicine at Sheba Medical Center in Israel and fellowship in Endocrinology and Diabetes at the Brigham and Women’s Hospital and Harvard Medical School in Boston, MA. Dr. Tirosh completed a post-doctoral training at the Department of Genetics and Complex Diseases at Harvard University. In 2018, Dr. Tirosh was appointed Director of the Division of Endocrinology, Diabetes and Metabolism at Sheba Medical Center. His main research activities include pathophysiology of obesity and diabetes and he is also extensively involved in clinical studies and translational projects in both type 1 and type 2 diabetes. Dr. Tirosh is a member of the Israeli National Council for Diabetes. He has received competitive grants from the National Institution of Health, the American Diabetes Association and the European Foundation for the Study of Diabetes. He has published over 100 peer-reviewed papers in scientific journals with over 5000 citations